As Vice President of Consultant Relations at Prime Therapeutics (Prime), Ann O’Brien oversees consultant business strategy and creates opportunities for growth in the self-insured and health plan markets. She leverages data resources to assess the current ASO and Health Plan business markets and determines market opportunity across the PBM landscape. She collaborates on strategy with Blues leadership, partners with Prime’s business units to construct proposals and marketing pieces, and builds trusted relationships across targeted consultant accounts.
Since joining Prime in 2017, O’Brien created and defined this new role, positively impacting Prime’s market growth and stability across employer groups. Previously, she held leadership roles at Walgreens, Dara BioSciences, Sandoz and Acorda Therapeutics. She has more than 20 years of experience within the pharmaceutical industry.
O’Brien earned a Bachelor of Science degree in nutrition and dietetics from Kent State University in Kent, Ohio.